Synergistic growth inhibition of cancer cells harboring the RET/PTC1 oncogene by staurosporine and rotenone involves enhanced cell death. [electronic resource]
Producer: 20120110Description: 639-48 p. digitalISSN:- 0973-7138
- Antineoplastic Combined Chemotherapy Protocols -- pharmacology
- Blotting, Western
- Carcinoma
- Carcinoma, Papillary -- drug therapy
- Cell Cycle Checkpoints -- drug effects
- Cell Death -- drug effects
- Cell Division -- drug effects
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Drug Synergism
- Flow Cytometry
- Fluorescent Antibody Technique
- Humans
- Oncogene Proteins, Fusion -- genetics
- Patched Receptors
- Proto-Oncogene Proteins c-ret -- genetics
- Receptors, Cell Surface -- genetics
- Rotenone -- pharmacology
- Staurosporine -- pharmacology
- Thyroid Cancer, Papillary
- Thyroid Gland -- drug effects
- Thyroid Neoplasms -- drug therapy
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.